Tristel Regulatory News (TSTL)

Tristel plc

("Tristel" or the "Company")

Director Appointment

Tristel plc (AIM: TSTL), leading manufacturer of infection prevention products, announces the appointment of Caroline Stephens to the Board as an Independent Non-Executive Director effective from 1 January 2021.

Caroline's executive career has been spent in global healthcare, marketing, and digital transformation, working for Johnson & Johnson for 26 years in multiple leadership roles.

Caroline holds a board advisory role with global digital transformation consultants CI&T.

It is expected that Caroline will join Tristel's Audit, Remuneration and Nomination committees.

Commenting on the appointment, Paul Swinney, CEO of Tristel, said: "I am delighted to welcome Caroline to the Board at such an exciting time for our Company. Caroline has extensive international and sector experience and we very much look forward to working with her."

For further information please contact:

Regulatory disclosure - The following information is disclosed in accordance with Rule 17 and paragraph (g) of Schedule 2 of the AIM Rules for Companies.

Caroline Jane Stephens, 53, holds no ordinary shares in the Company and no options. Caroline Stephen's current and previous directorships/partnerships are as follows:

Current Directorships/Partnerships:

Rex Bakery Ltd

Glendevon Trading Ltd

Verve Portfolio Ltd

Former Directorships/Partnerships held in last 5 years:

None

Save for the disclosures above, there are no further disclosures to be made in accordance with Rule 17 and Schedule 2(g) of the AIM Rules.